MX173196B - Metodo para producir un implanto de liberacion controlada y el producto obtenido con el mismo - Google Patents

Metodo para producir un implanto de liberacion controlada y el producto obtenido con el mismo

Info

Publication number
MX173196B
MX173196B MX027091A MX2709186A MX173196B MX 173196 B MX173196 B MX 173196B MX 027091 A MX027091 A MX 027091A MX 2709186 A MX2709186 A MX 2709186A MX 173196 B MX173196 B MX 173196B
Authority
MX
Mexico
Prior art keywords
controlled release
produce
product obtained
release implant
protein
Prior art date
Application number
MX027091A
Other languages
English (en)
Inventor
Alvin M Janski
Ren-Der Yang
Original Assignee
Int Minerals & Chem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Int Minerals & Chem Corp filed Critical Int Minerals & Chem Corp
Publication of MX173196B publication Critical patent/MX173196B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a un metodo para producir un implanto de liberación controlada, para administrar la hormona de crecimiento a un animal, caracterizado poque comprende los pasos de: (a) recuperar la hormona de crecimiento del animal, apartir de microorgamismos transformantes enun medio de fermentación, conteniendo los microorganismos transformantes un geneexpresadle que codifica la hormona de crecimiento del animal; (b) dializar la hormona de crecimiento del animal contra un regulador de diàlisis a un pH básico o fisiológico, en la escala de 9.6 a 10 a una temperatura de aproximadamente 5 a 15 grados C hasta que la cantidad de sal presente en la hormona del crecimiento recuperado del medio de fermentación sea mejor que 5 pr ciento, produciendo de esa manera una hormona de crecimiento con bajo contenido de sal; (c) liofilizar la hormona de crecimiento de bajo contenido de sal a una temperatura de aproximadamente 40 grados C durante el congelamiento, y a una temperatura de aproximadamente 25 grados C durante la sublimación; (d) mezclar la hormona de crecimiento de bajo contenido de sal, liofilizada, con un polímero compatible para producir una composición comprimible; e) comprimir la composición a una forma de dosis unitaria, capaz de ser implantada subcutáneamente.
MX027091A 1985-07-15 1986-07-15 Metodo para producir un implanto de liberacion controlada y el producto obtenido con el mismo MX173196B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/755,093 US4786501A (en) 1985-07-15 1985-07-15 Cylindrical implants for the controlled release of growth hormones

Publications (1)

Publication Number Publication Date
MX173196B true MX173196B (es) 1994-02-07

Family

ID=25037706

Family Applications (1)

Application Number Title Priority Date Filing Date
MX027091A MX173196B (es) 1985-07-15 1986-07-15 Metodo para producir un implanto de liberacion controlada y el producto obtenido con el mismo

Country Status (18)

Country Link
US (1) US4786501A (es)
EP (1) EP0210039B1 (es)
JP (2) JPH0822820B2 (es)
KR (1) KR930008952B1 (es)
CN (1) CN1026862C (es)
AT (1) ATE84707T1 (es)
AU (1) AU604639B2 (es)
BR (1) BR8603315A (es)
CA (1) CA1288196C (es)
DE (1) DE3687551T2 (es)
DK (1) DK173165B1 (es)
ES (1) ES2002099A6 (es)
IE (1) IE62302B1 (es)
IL (1) IL79403A0 (es)
MX (1) MX173196B (es)
NZ (1) NZ216832A (es)
PT (1) PT82978B (es)
ZA (1) ZA865271B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137874A (en) * 1985-07-29 1992-08-11 American Cyanamid Co. Partially coated C10 -C20 fatty acid salts of peptides having molecular weights up to about 5,000
US4761289A (en) * 1986-10-10 1988-08-02 International Minerals & Chemical Corp. Sustained release implant and method for preparing same
US4863736A (en) * 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
US4837202A (en) * 1987-09-14 1989-06-06 Pitman-Moore, Inc. Method for stimulating the immune system
US5035891A (en) * 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
US5100668A (en) * 1988-06-14 1992-03-31 Massachusetts Institute Of Technology Controlled release systems containing heparin and growth factors
EP0353045B1 (en) * 1988-07-26 1995-11-15 Rutgers, The State University of New Jersey Devices and methods for growth promotion in poultry roasters
US5179080A (en) * 1989-08-31 1993-01-12 Clinical Homecare, Corp. Formulations containing growth hormone and nutritional supplements, and methods of treating malnutrition in chronic lung disease
US5091185A (en) * 1990-06-20 1992-02-25 Monsanto Company Coated veterinary implants
US5232708A (en) * 1990-06-20 1993-08-03 Monsanto Company Coated veterinary implants
US5922342A (en) * 1990-10-01 1999-07-13 Pharmacia & Upjohn Company Lateral edge coated controlled release pharmaceutical compositions
IS3778A7 (is) * 1990-10-31 1992-05-02 Amgen Inc. Aðferð til að gefa dýrum vaxtarhormón, þar sem gefnu magni er stýrt
SE9303068D0 (sv) * 1993-09-21 1993-09-21 Kabi Pharmacia Ab New use
ES2139081T3 (es) * 1994-06-17 2000-02-01 Applied Res Systems Ars Holding N V Composiciones farmaceuticas que contienen la hormona humana del crecimiento.
US5595752A (en) * 1994-07-01 1997-01-21 Monsanto Company Increasing dressing percentage and carcass weight in finishing beef cattle
US5672357A (en) * 1994-07-01 1997-09-30 Monsanto Company Method and device for implantation of large diameter objects in bovines
IT1269221B (it) 1994-11-25 1997-03-21 Fondazione Clinica Del Lavoro Campionatore diffusivo a simmetria radiale di sostanze volatili, ad alta capacita' di pompaggio equivalente ed utile per il desorbimento chimico e termico.
AU744606B2 (en) * 1996-12-20 2002-02-28 Scientec Research Pty Ltd Apparatus and method for coating a material
AUPO431596A0 (en) * 1996-12-20 1997-01-23 Scientec Research Pty Ltd Apparatus and method for coating a material
KR19990071255A (ko) 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
ATE281155T1 (de) * 1998-04-20 2004-11-15 Genzyme Corp Medikamentöse verabreichung von proteinen aus polymergemischen
CA2451187C (en) * 2001-06-22 2012-08-14 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
US20060051347A1 (en) 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
US9763788B2 (en) 2005-09-09 2017-09-19 Board Of Trustees Of The University Of Arkansas Bone regeneration using biodegradable polymeric nanocomposite materials and applications of the same
US8518123B2 (en) * 2005-09-09 2013-08-27 Board Of Trustees Of The University Of Arkansas System and method for tissue generation and bone regeneration
US8936805B2 (en) 2005-09-09 2015-01-20 Board Of Trustees Of The University Of Arkansas Bone regeneration using biodegradable polymeric nanocomposite materials and applications of the same

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4450150A (en) * 1973-05-17 1984-05-22 Arthur D. Little, Inc. Biodegradable, implantable drug delivery depots, and method for preparing and using the same
US3993072A (en) * 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
US4158526A (en) * 1978-01-09 1979-06-19 General Electric Company Turbine assembly including a rotatable liquid collection ring
US4443539A (en) * 1980-02-05 1984-04-17 The Upjohn Company Process for preparing bovine growth hormone
IL59690A (en) * 1980-03-24 1983-11-30 Yeda Res & Dev Production of bovine growth hormone by microorganisms and modified microorganisms adapted to produce it
IE52755B1 (en) * 1980-08-26 1988-02-17 Univ California Bovine pre-growth and growth hormone
EP0085036A1 (en) * 1982-01-18 1983-08-03 Monsanto Company Method for improved bovine milk production
DE3214667C2 (de) * 1982-04-21 1985-07-18 Akzo Gmbh, 5600 Wuppertal Zusammengesetzter Körper für die Langzeitabgabe von Wirkstoffen
EP0103395A3 (en) * 1982-08-17 1985-05-22 Biogen N.V. Dna sequences, recombinant dna molecules and processes for producing bovine growth hormone-like polypeptides in high yield
CA1341012C (en) * 1982-09-27 2000-06-06 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing swine growth hormone-like polypeptides
US4511502A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4511503A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4512922A (en) * 1982-12-22 1985-04-23 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
US4506680A (en) * 1983-03-17 1985-03-26 Medtronic, Inc. Drug dispensing body implantable lead
US4755465A (en) * 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
US4563489A (en) * 1984-02-10 1986-01-07 University Of California Biodegradable organic polymer delivery system for bone morphogenetic protein
AU4403885A (en) * 1984-05-11 1985-12-13 Codon Genetic Engineering Laboratories An efficient process for producing active chymosin from a precursor protein synthesized in bacteria
US4686098A (en) * 1984-05-14 1987-08-11 Merck & Co., Inc. Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone DNA, and a method of administering BGH in vivo
EP0193917A3 (en) * 1985-03-06 1987-09-23 American Cyanamid Company Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration
US4670249A (en) * 1985-04-12 1987-06-02 International Minerals & Chemical Corp. Growth-promoting compositions
US4666704A (en) * 1985-05-24 1987-05-19 International Minerals & Chemical Corp. Controlled release delivery system for macromolecules

Also Published As

Publication number Publication date
KR870000924A (ko) 1987-03-10
JPS6253928A (ja) 1987-03-09
DK173165B1 (da) 2000-02-21
PT82978A (en) 1986-08-01
EP0210039B1 (en) 1993-01-20
EP0210039A3 (en) 1988-07-06
BR8603315A (pt) 1987-02-24
ATE84707T1 (de) 1993-02-15
DE3687551T2 (de) 1993-05-13
ZA865271B (en) 1987-03-25
JPH08205888A (ja) 1996-08-13
CA1288196C (en) 1991-08-27
AU6020186A (en) 1987-01-22
EP0210039A2 (en) 1987-01-28
CN1026862C (zh) 1994-12-07
ES2002099A6 (es) 1988-07-16
DK336986D0 (da) 1986-07-15
DK336986A (da) 1987-01-16
AU604639B2 (en) 1991-01-03
KR930008952B1 (ko) 1993-09-17
NZ216832A (en) 1989-01-06
IE62302B1 (en) 1995-01-25
CN86105858A (zh) 1987-06-03
US4786501A (en) 1988-11-22
PT82978B (pt) 1988-07-01
JPH0822820B2 (ja) 1996-03-06
DE3687551D1 (de) 1993-03-04
IL79403A0 (en) 1986-10-31
IE861876L (en) 1987-01-15

Similar Documents

Publication Publication Date Title
MX173196B (es) Metodo para producir un implanto de liberacion controlada y el producto obtenido con el mismo
DE3782420D1 (de) Wachstumhormonzubereitungen mit verzoegerter wirkstoffabgabe fuer eine parenterale verabreichung und ihre verwendung.
NZ227788A (en) Peptide having growth hormone regulatory effects, and compositions
NZ227787A (en) Peptides and compositions having growth hormone regulatory effects
HUT62798A (en) Process for producing pharmaceutical composition with slimming activity
PL254033A1 (en) Method of obtaining calcium salt of pseudomonic acid
EP0281809A3 (en) Sustained release compositions for parenteral administration and their use
DE69209173D1 (de) Implantationzusammensetzungen, die biologisch aktive Proteine, Peptide oder Polypeptide enthalten
NZ217525A (en) Administration of growth hormone to animals
MY100892A (en) Veterinary preparations.
DK0555785T3 (da) Glat-muskel-mitogent stof og DNA, der koder herfor
FR2684878B1 (fr) Composition pharmaceutique stabilisee d'il2 humaine recombinante non glycosylee sous forme reduite et son procede de preparation.
DE69021210D1 (de) Vogel-Interleukin-2 zur Wachstumssteigerung von Vögeln.
ATE88354T1 (de) Koerperqualitaet.
ES2020562B3 (es) Metodo para regular la reproduccion animal.
DE3789550D1 (de) Verfahren zur herstellung eines rinderwachstumshormons mittels eines kunstgens.
DK79293A (da) Formulering med langsom frigivelse, dens fremstilling og anvendelse til foroegelse af maelkeproduktion i maelkegivende dyr
ATE66611T1 (de) Verwendung biologisch aktiver copolymere zur herstellung eines arzneimittels zur stimulierung des wachstums von tieren.
BG50927A3 (bg) Метод за получаване на стабилизирани стимулиращи растежа хормони